Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-030189

Chief Executive Officer sold 14,385 shares at an average $77.04 ($1,108,263)

  • Chief Executive Officer acquired 28,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2024-03-10 Option exercise +19,250 213,507 D
Kulkarni Samarth Chief Executive Officer 2024-03-11 Sale −9,802 $78.26 $767,105 203,705 D
Kulkarni Samarth Chief Executive Officer 2024-03-11 Option exercise +9,000 212,705 D
Kulkarni Samarth Chief Executive Officer 2024-03-12 Sale −4,583 $74.44 $341,159 208,122 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2024-03-10 Option exercise · Restricted Stock Units −19,250 57,750 D
Kulkarni Samarth Chief Executive Officer 2024-03-11 Option exercise · Restricted Stock Units −9,000 9,000 D
Open-market sales · 14,385 sh · avg $77.04 · $1,108,263
Loading xslF345X05/ownership.xml…